Breast Cancer

Breast Health

COVID-19

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Labor and Delivery

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Procedures

Sexual Dysfunction

Sexual Health

Sexually Transmitted Diseases

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Print Subscription

eNewsletter

Editorial Board

Partnerships

Joshua Fitch is an editor for Contemporary Pediatrics. Previously, he worked at 21 WFMJ as a sports anchor and videographer, as well as a national content writer for Weigel Broadcasting Company. 

Articles

Ahead of the first fall and winter virus seasons in which vaccines are available for COVID-19, influenza, and respiratory syncytial virus (RSV), the Centers for Disease Control and Prevention is recommending Pfizer’s maternal vaccine to protect newborns from severe RSV illness.

CDC recommends Pfizer’s maternal RSV vaccine to protect newborns

In a recent study, ages at menarche and menopause, as well as pregnancy history, impacted the risk of endometrial cancer.

Reproductive factors found to influence endometrial cancer risk

In a recent study, Black patients experienced more delays in receiving endometrial cancer care than White patients.

Racial disparities reported in endometrial cancer care

The presence of NAFLD increased from 25.3% to 29.4% among patients receiving oral menopause hormone therapy.

Oral menopause hormone therapy linked to increased risk of NAFLD

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Twitter

Facebook

LinkedIn

RSS Feed

Spotlight

Advances in the Management of Uterine Fibroids

CMV: In the Know

Expert Perspectives on Advances in Cervical Cancer Screening

NPWH

Supplement: Closing the Gap in Cervical Cancer Screening

Updates in the Pharmacotherapy of Endometriosis

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

Authors

Genomic testing has grown in importance as the number of targeted anticancer therapies rises. Early genomic testing can help to guide treatment choices.

Overcoming barriers to genomic testing in community care settings

Darcy Lewis

Articles